SPONTANEOUS IMPROVEMENT IN A PATIENT WITH JUVENILE PITYRIASIS RUBRA PILARIS
Keywords:
Pityriasis Rubra Pilaris, juvenile form, local treatment, childrenAbstract
Pityriasis rubra pilaris (PRP) is a rare and complex dermatosis characterized by erythematous plaques, follicular papules, hyperkeratosis, and scaling. While its precise etiology remains largely unidentified, genetic predisposition, immune-mediated mechanisms, and environmental triggers are implicated in its pathogenesis.
We present a case of a 3-year-old child with a 1-month history of erythematous macules, initially affecting the hands, feet, perioral, and periocular regions. The lesions were initially recognized by a dermatologist and pediatrician as hand, foot, and mouth disease (HFMD). Two weeks later, the patient developed widespread involvement of 80% of the skin surface, including the face. Considering the evolutionary progression of the clinical changes, a diagnosis of pityriasis rubra pilaris (PRP) was established.
After 6 weeks of local treatment with corticosteroids and emollients, significant reduction in body surface area (BSA) was observed. The idea of initiating systemic therapy with acitretin was dismissed, given the favorable course of the disease. After 5 months of clinical observation, the patient achieved complete resolution of the skin changes, highlighting the self-limiting nature of the juvenile form. The patient underwent frequent check-ups for 1 year, and no changes or relapses were observed. This case highlights the value of conservative management and vigilant monitoring in achieving long-term resolution and minimizing the need for systemic interventions.
References
Wang D, Chong VC, Chong WS, Oon HH. A review on pityriasis rubra pilaris. Am J Clin Dermatol. 2018;19(3):377–90. doi:10.1007/s40257-017-0338-1
Montero Menárguez J, Amat Samaranch V, Puig Sanz L, et al. Pityriasis rubra pilaris: a multicentric case series of 65 Spanish patients. Actas Dermosifiliogr. 2024 Sep;115(8):761–5. doi:10.1016/j.ad.2024.02.019
Griffiths WA. Pityriasis rubra pilaris. Clin Exp Dermatol. 1980;5(1):105–12. doi:10.1111/j.1365-2230.1980.tb01676.x
Miralles ES, Núñez M, De Las Heras ME, Pérez B, Moreno R, Ledo A. Pityriasis rubra pilaris and human immunodeficiency virus infection. Br J Dermatol. 1995;133(6):990–3. doi:10.1111/j.1365-2133.1995.tb06939.x
Joshi TP, Duvic M. Pityriasis rubra pilaris: an updated review of clinical presentation, etiopathogenesis, and treatment options. Am J Clin Dermatol. 2024 Mar;25(2):243–59. doi:10.1007/s40257-023-00836-x
Van Geel MM, De Langhe E, Lapeere H, et al. Pityriasis rubra pilaris: algorithms for diagnosis and treatment. J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1856–64. doi:10.1111/jdv.14761
Gonçalo M, Rodrigues AM, Silva F. Retrospective study of the treatment of pityriasis rubra pilaris: an analysis of 78 treatment courses. Br J Dermatol. 2020;183(4):673–81. doi:10.1111/bjd.18951
Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol. 2010;11(3):157–70. doi:10.2165/11530070-000000000-00000
Soeprono FF. Histologic criteria for the diagnosis of pityriasis rubra pilaris. Am J Dermatopathol. 1986;8(4):277–83. doi:10.1097/00000372-198608000-00001
Gelmetti C, Schiuma AA, Cerri D, Gianotti F. Pityriasis rubra pilaris in childhood: a long-term study of 29 cases. Pediatr Dermatol. 1986;3(6):446-51. doi: 10.1016/j.ejca.2023.113343.